Atorvastatin + Ezetimibe

Information about Atorvastatin + Ezetimibe

Atorvastatin + ezetimibe uses

Atorvastatin+Ezetimibe is used in the treatment of high cholesterol.

How atorvastatin + ezetimibe works

Atorvastatin and ezetimibe. Atorvastatin is a lipid-lowering medicine which prevents your body from making "bad" cholesterol (LDL) while raising "good" cholesterol (HDL) levels. Ezetimibe is a cholesterol absorption inhibitor which prevents absorption of cholesterol from the intestines. Together, they provide better reduction of cholesterol in your body.

Common side effects of atorvastatin + ezetimibe

Muscle pain, Nausea, Increased transaminase level in blood, Upper respiratory tract infection, Muscle spasm, Rash, Red spots or bumps, Increased creatine phosphokinase (CPK) level in blood, Muscle damage, Rhabdomyolysis, Anaphylactic reaction, Immune-mediated necrotizing myopathy

Available Medicine for Atorvastatin + Ezetimibe

  • ₹237 to ₹279
    Sun Pharmaceutical Industries Ltd
    2 variant(s)
  • ₹334 to ₹436
    Intas Pharmaceuticals Ltd
    3 variant(s)
  • ₹168 to ₹279
    Sun Pharmaceutical Industries Ltd
    2 variant(s)
  • ₹367 to ₹411
    Zydus Cadila
    2 variant(s)
  • ₹260
    Emcure Pharmaceuticals Ltd
    1 variant(s)
  • ₹244 to ₹589
    Lupin Ltd
    4 variant(s)
  • ₹192
    Micro Labs Ltd
    1 variant(s)
  • ₹242
    Torrent Pharmaceuticals Ltd
    1 variant(s)
  • ₹150 to ₹195
    Eris Lifesciences Ltd
    3 variant(s)
  • ₹105
    FDC Ltd
    1 variant(s)

Expert advice for Atorvastatin + Ezetimibe

  • You have been prescribed Atorvastatin + Ezetimibe for the treatment of high cholesterol.
  • Take it in addition to regular exercise and low-fat diet to lower levels of fat in the blood.
  • It can be taken with or without food.
  • Notify your doctor if you experience muscle symptoms (pain or weakness), particularly if accompanied with fever.
  • Notify your doctor if you experience stomach pain, loss of hunger, a sick feeling or dark urine.


Content on this page was last updated on 28 August, 2024, by Dr. Varun Gupta (MD Pharmacology)